AKEBIA THERAPEUTICS INC shareholders Q2 2023

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

AKEBIA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
VICTORY CAPITAL MANAGEMENT INC 661,898$605,6370.00%
Advisory Services Network, LLC 27,000$24,7050.00%
Visionary Wealth Advisors 14,819$13,5590.00%
GTS SECURITIES LLC 17,549$16,0570.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 50,000$45,7500.00%
Graham Capital Management, L.P. 26,586$24,3260.00%
MILLENNIUM MANAGEMENT LLC 2,005,958$1,835,4520.00%
Qube Research & Technologies Ltd 436,269$399,1860.00%
UBS Group AG 71,488$65,4120.00%
RAYMOND JAMES & ASSOCIATES 11,602$10,6160.00%
Capital Advisors, Ltd. LLC 320$00.00%
JPMORGAN CHASE & CO 37,903$34,6810.00%
JANE STREET GROUP, LLC 57,111$52,2570.00%
First Horizon Advisors, Inc. 5,600$5,1240.00%
Focused Wealth Management, Inc 65$590.00%
Hexagon Capital Partners LLC 186$1700.00%
FMR LLC 613,590$561,4350.00%
VANGUARD GROUP INC 7,811,061$7,147,1210.00%
BALDWIN BROTHERS LLC/MA 561$5130.00%
OSAIC HOLDINGS, INC. 739$6760.00%
External links

This page lists AKEBIA THERAPEUTICS INC's shareholders in Q2 2023. To view AKEBIA THERAPEUTICS INC's shareholder history, click here.